Merck & Co., Inc. (MRK) - Stock Analysis

Merck & Co., Inc. Financial Analysis

Current Price: $126.27 +1.50%

Market Cap: $311.86B

Sector: Healthcare

P/E Ratio: 14.43

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhil

Report Contents

  • Income Statement Analysis (5-year history)
  • Balance Sheet Overview
  • Cash Flow Statement
  • Key Financial Ratios
  • Valuation Metrics (P/E, EV/EBITDA, P/S)
  • Peer Comparison
  • Revenue & Earnings Growth Trends
  • Margin Analysis
  • Analyst Price Targets
  • DCF Valuation Model